RVPH

RVPH

USD

Reviva Pharmaceuticals Holdings Inc. Common Stock

$0.553-0.017 (-2.982%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$0.570

Haut

$0.595

Bas

$0.530

Volume

5.53M

Fondamentaux de l'Entreprise

Capitalisation Boursière

53.3M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

9.52M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.25Actuel $0.553Haut $4.28

Actualités Connexes

Analyst Upgrades

D. Boral Capital Maintains Buy on Reviva Pharmaceuticals, Maintains $2 Price Target

D. Boral Capital analyst Jason Kolbert maintains Reviva Pharmaceuticals with a Buy and maintains $2 price target.

Voir plus
D. Boral Capital Maintains Buy on Reviva Pharmaceuticals, Maintains $2 Price Target
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Reviva Pharmaceuticals, Lowers Price Target to $4

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Reviva Pharmaceuticals with a Buy and lowers the price target from $11 to $4.

Voir plus
HC Wainwright & Co. Maintains Buy on Reviva Pharmaceuticals, Lowers Price Target to $4
GlobeNewswire

Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners

CUPERTINO, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet

Voir plus
Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.